Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Unknown × Denosumab × Clear all

Phase

Phase 3 3 Phase 2 3 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 33 Paclitaxel 27 Carboplatin 25 Gemcitabine 24 Nivolumab 23 Cisplatin 22 camrelizumab 21 Capecitabine 20 fludarabine 19 apatinib 19 toripalimab 17 Oxaliplatin 17 Immunotherapy, Adoptive 17 pembrolizumab 15 Radiotherapy 15 Drug Therapy 14 Bevacizumab 14 Rituximab 13 Docetaxel 13 tislelizumab 12 Temozolomide 12 Injections 11 Dexamethasone 11 Cetuximab 11 Irinotecan 10 Cytarabine 10 anlotinib 9 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 9 130-nm albumin-bound paclitaxel 9 Trastuzumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03161756 2022-04-07

CHARLI

Melanoma and Skin Cancer Trials Limited

Phase 1/2 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡